NEW YORK (GenomeWeb News) – The US Food and Drug Administration has approved a hepatitis C viral load assay made by Siemens Healthcare that can help physicians to monitor the disease, the company said today.
 
Siemens said its Versant 440 Molecular System was approved for marketing and for use with the company’s Versant HCV RNA 3.0 assay for management of HCV-infected patients.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.